Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of MDMA and Methamphetamine on Social Motivation (MASM)
NCT05379959Phase 1Completed
- Sponsor
- University of Chicago
- Start
- May 2022
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of midomafetamine in Social Anxiety Disorder (SAD), sponsored by University of Chicago. Primary endpoint: Profile of Mood States at 72 hours. Started May 2022; status: completed.
02
Drugs
midomafetamine
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT05379959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05379959.